Annexon, Inc. (ANNX) Financials

ANNX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 262.9 million 58.4 million
Dec. 31, 2025 277.6 million 65.9 million
Sept. 30, 2025 229.1 million 67.7 million
June 30, 2025 264.6 million 65.6 million

ANNX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -46.8 million 4.2 million
Dec. 31, 2025 -45.9 million 3.3 million
Sept. 30, 2025 -52.4 million 3.8 million
June 30, 2025 -38.1 million 4.2 million

ANNX Net Income

No data available :(

ANNX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 225.0 million - 22.4 million
Dec. 31, 2025 238.3 million - 26.2 million
Sept. 30, 2025 188.7 million - 26.9 million
June 30, 2025 227.0 million - 27.6 million

ANNX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 194.2 million
Dec. 31, 2025 155.1 million
Sept. 30, 2025 149.1 million
June 30, 2025 148.3 million

ANNX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 35.8 million 10.3 million -
Dec. 31, 2025 - 42.7 million 8.2 million -
Sept. 30, 2025 48000 49.7 million 7.3 million -
June 30, 2025 15000 44.2 million 7.0 million -

ANNX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 957000
Dec. 31, 2025 - 945000
Sept. 30, 2025 - -
June 30, 2025 - 912000

ANNX

Price: $4.49

52 week price:
1.85
7.18

Earnings Per Share: -1.20 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 124730

Market Capitalization: 644.6 million

Links: